Clinical Trials

Lung Cancer Trial Finder

Click on the headings below to view relevant trials for the condition listed. All the trials below are for non-small-cell lung cancer (NSCLC). SCCA currently does not currently have any trials open for small-cell lung cancer (SCLC).

Lung Cancer: Newly Diagnosed (1 trial)

Trials for Special Populations (5 trials)

Advanced/Metastatic Disease 1st Line and Maintenance (3 trials)

  • MEDI4736 (Anti PD-L1) w/ Gefitinib for Non-Small Cell Lung Cancer (UW14005)
    A Phase I, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumour Activity of Gefitinib in Combination With MEDI4736 (Anti PD-L1) in Subjects With Non-Small Cell Lung Cancer(NSCLC)
  • Advanced/Metastatic Disease 2nd Line (5 trials)

  • Alisertib (MLN8237) in Combination With Paclitaxel for Small Cell Lung Cancer (UW14002)
    A Randomized, Double-blind, Placebo-controlled, Phase 2 Clinical Trial of Alisertib (MLN8237) in Combination With Paclitaxel Versus Placebo in Combination With Paclitaxel as Second Line Therapy for Small Cell Lung Cancer (SCLC).
  • Advanced/Metastatic Disease Beyond 2nd Line (2 trials)

    Early Stage/Locally Advanced Disease (1 trial)

    Upcoming Trials (3 trials)

    Clinical Trial Finder beta 2 updated 8/5/14.